April 20, 2018 9:12 PM ET

Pharmaceuticals

Company Overview of MOTUS THERAPEUTICS, INC.

Key Executives for MOTUS THERAPEUTICS, INC.

NameBoard RelationshipsTitleAge
Keith Michael Gottesdiener 26 RelationshipsChief Executive Officer and Director63
Bart Henderson MBANo RelationshipsFounder and President58
Elizabeth Stoner M.D., M.S.46 RelationshipsFounder and Member of Scientific Advisory Board67
Fred T. Fiedorek M.D.No RelationshipsChief Medical Officer62
Leonardus H.T. van der Ploeg Ph.D.36 RelationshipsChief Scientific Officer62

MOTUS THERAPEUTICS, INC. Board Members*

NameBoard RelationshipsPrimary CompanyAge
David P. Meeker 27 RelationshipsSanofi US Services Inc.63
Keith Michael Gottesdiener 26 RelationshipsRhythm Pharmaceuticals, Inc.63
Elizabeth Stoner M.D., M.S. 46 RelationshipsRhythm Holding Company, LLC67
Lee M. Kaplan M.D., Ph.D. 105 RelationshipsZafgen, Inc.--
Todd Foley MBA 38 RelationshipsMPM Capital45
View All Board Members

MOTUS THERAPEUTICS, INC. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.Lee M. Kaplan105 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
319.3K
Bonus
272.5K
Total Short Term Compensation
323.4K
Total Value of Options
10.1M
Compensation as of Fiscal Year
MOTUS THERAPEUTICS, INC. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Canndeo Appoints Ken Charteris as Executive Director
April 12, 2018 5:15 AM ET
The Hydroponics Company Limited Appoints Henry Kinstlinger as Joint Company Secretary
April 12, 2018 5:15 AM ET
Herantis Pharma Oyj Elects Pekka Mattila as Chairman of the Board
April 11, 2018 2:00 PM ET
Earth Science Tech, Inc. Appoints Jad Nammour as the New Chief of Pharmacy
April 11, 2018 12:35 PM ET
Verona Pharma plc Announces Resignation of Kenneth Newman as Chief Medical Officer, Effective April 30, 2018
April 11, 2018 6:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MOTUS THERAPEUTICS, INC., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.